A not-for-profit company, any surplus income is reinvested for blood cancer patients’ benefit.
Delivery of both academic investigator initiated and industry sponsored clinical trials in haemato-oncology are accelerated with the resource and expertise of ACT and the networks, TAP and IMPACT.
This company has no teams yet
One Young World
3 followers
Instrumentl
3 followers
Morphle Labs
3 followers
Dentira
3 followers
Greenburgh Nature Center
2 followers
Breast Cancer Now
2 followers
Hertility Health
3 followers
Midi Health
2 followers
Aperture
2 followers
Bone Cancer Research Trust
2 followers
Canadian Institute of Mining, Metallurgy and Petroleum
2 followers